These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Nebulized bacteriostatic saline as a cause of bronchitis. Reynolds RD; Smith RM J Fam Pract; 1995 Jan; 40(1):35-40. PubMed ID: 7807035 [TBL] [Abstract][Full Text] [Related]
10. [Glucan solution nasal spray vs saline in the treatment of chronic rhinosinusitis: a multi-centric double blind randomised clinical trial]. Passali D; Fiorella R; Camaioni A; Villari G; Mora E; Passali GC; Passali FM; Crisanti A; Bellussi L Clin Ter; 2007; 158(2):139-45. PubMed ID: 17566515 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study. Carr DB; Goudas LC; Denman WT; Brookoff D; Staats PS; Brennen L; Green G; Albin R; Hamilton D; Rogers MC; Firestone L; Lavin PT; Mermelstein F Pain; 2004 Mar; 108(1-2):17-27. PubMed ID: 15109503 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Banov CH; Lieberman P; Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234 [TBL] [Abstract][Full Text] [Related]
13. Long-term use of preservatives on rat nasal respiratory mucosa: effects of benzalkonium chloride and potassium sorbate. Cho JH; Kwun YS; Jang HS; Kang JM; Won YS; Yoon HR Laryngoscope; 2000 Feb; 110(2 Pt 1):312-7. PubMed ID: 10680936 [TBL] [Abstract][Full Text] [Related]
14. [The tolerability of nasal drugs with special regard to preservatives and physico-chemical parameters]. Verse T; Sikora C; Rudolph P; Klöcker N Laryngorhinootologie; 2003 Nov; 82(11):782-9. PubMed ID: 14634896 [TBL] [Abstract][Full Text] [Related]
15. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study. Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the efficacy of measures to reduce pain after subcutaneous administration of epoetin alfa. Frenken LA; van Lier HJ; Koene RA Nephrol Dial Transplant; 1994; 9(9):1295-8. PubMed ID: 7816293 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. Penagos M; Compalati E; Tarantini F; Baena-Cagnani CE; Passalacqua G; Canonica GW Allergy; 2008 Oct; 63(10):1280-91. PubMed ID: 18721246 [TBL] [Abstract][Full Text] [Related]
18. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study. Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816 [TBL] [Abstract][Full Text] [Related]
19. Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions. Marple B; Roland P; Benninger M Otolaryngol Head Neck Surg; 2004 Jan; 130(1):131-41. PubMed ID: 14726922 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]